Fundz

Arch Therapeutics, Inc. reported raising $6.9 Million in an initial SEC Form D filing, from an offering of $7.52 Million

PRIVATEFeb 25, 2021$6.9M of $7.5M raised

Amount Raised

$6.9 Million

$6.9 Million sold, per SEC Form D (first sale Feb 25, 2021)

Round Type

Venture

FraminghamBiotechnology

Quick answer

Arch Therapeutics raised $6.9 Million in a funding round, dated February 25, 2021. Arch Therapeutics is based in Framingham, Massachusetts, United States.

How much did Arch Therapeutics raise?
Arch Therapeutics raised $6.9 Million in a funding round on February 25, 2021.
What does Arch Therapeutics do?
Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care.
Where is Arch Therapeutics based and how big is it?
Arch Therapeutics is based in Framingham, Massachusetts, United States.
Who are the decision-makers at Arch Therapeutics?
Fundz holds 1 contact at Arch Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Arch Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • ExpressCells, Inc. raised $591K (Seed) on April 9, 2021.
  • Arcellx, Inc raised $115M on April 9, 2021.
  • selectIon raised $5.1M on April 8, 2021.
  • Revel Pharmaceuticals Inc. raised $800K (Seed) on April 8, 2021.
  • Ventus Therapeutics raised $100M (Series B) on April 8, 2021.
  • Vizgen raised $37M on April 8, 2021.

Who to call at Arch Therapeutics, and when

A new round usually means Arch Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arch Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arch Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arch Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arch Therapeutics

Location

235 WALNUT STREET, SUITE 6

Framingham, Massachusetts, United States

About

Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch has received regulatory authorization to market AC5® Advanced Wound System and AC5® Topical Hemostat as medical devices in the United States and Europe, respectively. Arch's development stage product candidates include AC5-G™, AC5-V® and AC5® Surgical Hemostat, among others

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arch Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDan Y., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Arch Therapeutics's next move

See what Strategic adds

Arch Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.